Ikena Oncology, Inc. (IKNA) Financials
IKNA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 192.1 million | 22.3 million |
2023-09-30 | 215.3 million | 60.0 million |
2023-06-30 | 171.8 million | 15.1 million |
2023-03-31 | 152.4 million | 17.4 million |
IKNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -22.1 million | 1.8 million |
2023-09-30 | -20.0 million | 2.0 million |
2023-06-30 | -18.1 million | 1.9 million |
2023-03-31 | -19.9 million | 2.0 million |
IKNA Net Income
No data available :(
IKNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 175.5 million | - | 10.7 million |
2023-09-30 | 196.9 million | - | 11.5 million |
2023-06-30 | 157.3 million | - | 5.0 million |
2023-03-31 | 137.8 million | - | 5.3 million |
IKNA Shares Outstanding
IKNA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 262000 | 14.0 million | 8.3 million | 1 |
2023-09-30 | - | 1.2 million | 6.0 million | - |
2023-06-30 | 4000 | 15.2 million | 5.3 million | - |
2023-03-31 | 152000 | 15.6 million | 5.3 million | - |
IKNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 659000 | 305000 |
2023-09-30 | 1.2 million | 242000 |
2023-06-30 | 2.0 million | 586000 |
2023-03-31 | 5.3 million | 568000 |
IKNA
Price: $1.30
52 week price:
Earnings Per Share: -1.63 USD
P/E Ratio: -0.93
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 7489
Market Capitalization: 61.3 million